Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Explore the Potential of UCH-L1 as a Novel Therapeutic and Diagnostic Target in Heart Failure

NCT04999995 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04999995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04999995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Explore the Potential of UCH-L1 as a Novel Therapeutic and Diagnostic Target in Heart Failure
Lead sponsor
VA Office of Research and Development
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
March 17, 2025
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspnea; cardiac, heart failure